Back to Search
TYLER FITCH, M.D.
M.D.
Internal Medicine Physician
NPI: 1992068936IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
OTHER
Class of 2008
Research & Publications (20)
Dopamine D1/5 receptor modulation of firing rate and bidirectional theta burst firing in medial septal/vertical limb of diagonal band neurons in vivo.
PMID 16452256·J Neurophysiol·2006
4-observational
Force transducer-based movement detection in fear conditioning in mice: a comparative analysis.
PMID 11918287·Hippocampus·2002
4-observational
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
PMID 19380443·J Clin Oncol·2009
3-trial
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
PMID 19129205·Ann Oncol·2009
3-trial
Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A.
PMID 19090009·Cancer·2009
3-trial
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
PMID 19047293·J Clin Oncol·2009
3-trial
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
PMID 18045731·Lung Cancer·2008
3-trial
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
PMID 17674351·Cancer·2007
2-rct
Paclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to mitigate toxicity and predict outcomes: North Central Cancer Treatment Group (N0044).
PMID 17921712·Am J Clin Oncol·2007
3-trial
Constructions and deconstructions of risk, resilience and wellbeing: a model for understanding the development of Aboriginal adolescents.
PMID 18027130·Australas Psychiatry·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 530 NE GLEN OAK AVE, #5607
PEORIA, IL 61637 - Phone
- (309) 655-3863
Quick Facts
- NPI
- 1992068936
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile